Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Clinical trial NCT02668653 · COMPLETED
Trial details
- NCT number
- NCT02668653
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2021-08-13
- Enrollment
- 539
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.